Becton, Dickinson and Company (BDX)
Medical devices & diagnostics • Medication management systems • Infusion therapy • Diagnostic instruments (Kiestra, Veritor) • Biosciences & flow cytometry • C.R. Bard legacy (catheters, surgical) • Dividend Aristocrat 53yr
MOS -26.7%Upside -21.1%P/E 36.56Yield 1.97%ROE 6.6%
รายงาน →👁 0 · 👍 02026-09-21